\n
Learning Outcomes<\/strong><\/p>\n\n\n\nTuesday 2nd September 2025 \u2018Identifying risk,\u00a0ongoing monitoring & standard care processes for adults with Type 2 Diabetes\u2019<\/strong> Please note this session will be held at 12pm-1pm<\/em><\/p>\n\n\n\n\n- To be confident in identifying those people who are at risk of type 2 diabetes<\/li>\n\n\n\n
- To be confident in determining an accurate diagnosis of type 2 diabetes<\/li>\n\n\n\n
- To be aware of the standards of care for type 2 diabetes<\/li>\n\n\n\n
- To identify the various methods required for the monitoring of type 2 diabetes<\/li>\n<\/ul>\n\n\n\n
Tuesday 4th November 2025 \u2018The Self-Care Challenge; supporting people with long term conditions<\/strong>\u2019<\/strong><\/p>\n\n\n\n\n- To understand how adopting a patient-centered approach can support people with effective self-management and change<\/li>\n\n\n\n
- To explore the potential conversational structure, language, and tools that promote motivation, self-management and change<\/li>\n\n\n\n
- To understand the Stages of Change model<\/li>\n\n\n\n
- To reflect on the best way to support patients with long-term conditions<\/li>\n<\/ul>\n\n\n\n
Wednesday 17th December 2025 \u2018Therapy Choices for adults with Type 2 Diabetes (Part A)<\/strong>\u2019<\/strong><\/p>\n\n\n\n\n- Discuss the considerations when choosing a treatment to meet the needs and circumstances of individual adult patients with type 2 diabetes<\/li>\n\n\n\n
- Review the standard oral therapies used in the treatment of type 2 diabetes: metformin, sulphonylureas, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors and oral GLP-1 RAs<\/li>\n\n\n\n
- Understand the sites of action for the different oral drug classes and be aware of the prescribing considerations including renal function and hepatic disease<\/li>\n\n\n\n
- Recognise the need to consider therapy specific factors and the individual patient\u2019s circumstances when choosing between different oral therapies<\/li>\n<\/ul>\n\n\n\n
Tuesday<\/strong> 20th<\/sup> January 2026<\/strong> \u2018Therapy Choices for adults with Type 2 Diabetes (Part B)\u2019<\/strong><\/p>\n\n\n\n\n- Discuss the considerations when choosing a treatment to meet the needs and circumstances of individual adult patients with type 2 diabetes<\/li>\n\n\n\n
- Review the standard oral therapies used in the treatment of type 2 diabetes: metformin, sulphonylureas, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors and oral GLP-1 RAs<\/li>\n\n\n\n
- Understand the sites of action for the different oral drug classes and be aware of the prescribing considerations including renal function and hepatic disease<\/li>\n\n\n\n
- Recognise the need to consider therapy specific factors and the individual patient\u2019s circumstances when choosing between different oral therapies<\/li>\n<\/ul>\n\n\n\n
Tuesday<\/strong> 3rd<\/sup> February 2026 \u2018Younger Adults with Type 2 Diabetes\u2019<\/strong><\/p>\n\n\n\n\n- The growing problem of type 2 diabetes (T2D) in younger adults<\/li>\n\n\n\n
- The importance of early identification and management<\/li>\n\n\n\n
- Psychosocial considerations in younger adults with T2D<\/li>\n\n\n\n
- Holistic approach to care in younger adults with T2D<\/li>\n<\/ul>\n\n\n\n
Tuesday<\/strong> 24th<\/sup> March 2026 \u2018Understanding Incretin Hormones & their role in the management of adults with Type 2 Diabetes\u2019<\/strong><\/p>\n\n\n\n\n- To understand the role of the incretin hormones, native GLP-1 and GIP, in humans<\/li>\n\n\n\n
- To discuss the effects of incretin-based therapy in people with T2D and its position in the treatment pathway<\/li>\n\n\n\n
- To review important considerations of risk management in diabetes<\/li>\n<\/ul>\n\n\n\n
Wednesday<\/strong> 29th<\/sup> April 2026<\/strong> \u2018Why Weight Matters in Type 2 Diabetes\u2019<\/strong><\/p>\n\n\n\n\n- To understand the links between weight & Type 2 diabetes and the impact of Type 2 Diabetes on people living with overweight\/obesity<\/li>\n\n\n\n
- To review the pathophysiology of Type 2 diabetes in people living with overweight and obesity<\/li>\n\n\n\n
- To recognise the importance and challenges of weight management in people with Type 2 Diabetes<\/li>\n\n\n\n
- To explore ways to support people in achieving their treatment and weight management goals<\/li>\n<\/ul>\n\n\n\n
Wednesday<\/strong> 10th<\/sup> June 2026<\/strong> (TBC)<\/strong><\/em><\/p>\n<\/div><\/div>\n\n<\/div>","protected":false},"excerpt":{"rendered":"Programme for 2025\/2026 Series of stand-alone webinars developed and delivered by LILLY, with local involvement from NHS Specialists will run from September 2025 through to June 2026. These webinars are non-promotional and<\/p>\n","protected":false},"author":27,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-templates\/fullwidth.php","meta":{"_searchwp_excluded":"","footnotes":""},"categories":[],"class_list":["post-1290","page","type-page","status-publish","hentry"],"rttpg_featured_image_url":null,"rttpg_author":{"display_name":"scottsamson","author_link":"https:\/\/staff.nhslothian.scot\/diabetesprofessionaleducation\/author\/scottsamson\/"},"rttpg_comment":0,"rttpg_category":false,"rttpg_excerpt":"Programme for 2025\/2026 Series of stand-alone webinars developed and delivered by LILLY, with local involvement from NHS Specialists will run from September 2025 through to June 2026. These webinars are non-promotional and","_links":{"self":[{"href":"https:\/\/staff.nhslothian.scot\/diabetesprofessionaleducation\/wp-json\/wp\/v2\/pages\/1290","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staff.nhslothian.scot\/diabetesprofessionaleducation\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/staff.nhslothian.scot\/diabetesprofessionaleducation\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/staff.nhslothian.scot\/diabetesprofessionaleducation\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/staff.nhslothian.scot\/diabetesprofessionaleducation\/wp-json\/wp\/v2\/comments?post=1290"}],"version-history":[{"count":8,"href":"https:\/\/staff.nhslothian.scot\/diabetesprofessionaleducation\/wp-json\/wp\/v2\/pages\/1290\/revisions"}],"predecessor-version":[{"id":1545,"href":"https:\/\/staff.nhslothian.scot\/diabetesprofessionaleducation\/wp-json\/wp\/v2\/pages\/1290\/revisions\/1545"}],"wp:attachment":[{"href":"https:\/\/staff.nhslothian.scot\/diabetesprofessionaleducation\/wp-json\/wp\/v2\/media?parent=1290"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staff.nhslothian.scot\/diabetesprofessionaleducation\/wp-json\/wp\/v2\/categories?post=1290"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}